title: What regulatory science can bring for CNS drug development.
authors.affiliation: Medicines Evaluation Board, Graadt van Roggeweg 500, Utrecht 3531 AH, The Netherlands. Electronic address: cc.gispen@cbg-meb.nl.
authors.forename: Christine
authors.initials: C
authors.lastname: Gispen-de Wied
authors.affiliation: Medicines Evaluation Board, Graadt van Roggeweg 500, Utrecht 3531 AH, The Netherlands.
authors.forename: Violeta
authors.initials: V
authors.lastname: Stoyanova-Beninska
mesh_terms: D000818:Animals; D035843:Biomedical Research; D002491:Central Nervous System Agents / Q000627:therapeutic use*; D055808:Drug Discovery / Q000331:legislation & jurisprudence* / Q000379:methods*; D006801:Humans; D009422:Nervous System Diseases / Q000188:drug therapy*
chemical_list: D002491:Central Nervous System Agents